Sanjeev Gangwar Selected Research

Therapeutics

1/2022	Discovery of Non-Nucleotide Small-Molecule STING Agonists via Chemotype Hybridization.
1/2019	Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapy.
1/2018	Adnectin-drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors.
1/2016	Streamlined Total Synthesis of Uncialamycin and Its Application to the Synthesis of Designed Analogues for Biological Investigations.
9/2003	CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjeev Gangwar Research Topics

Disease

13	Neoplasms (Cancer) 02/2024 - 09/2003
2	Carcinoma (Carcinomatosis) 10/2020 - 09/2003
1	Bites and Stings (Sting) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2013
1	Leukemia 09/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2003

Drug/Important Bio-Agent (IBA)

11	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 05/2013
4	Cytotoxins (Cytolysins)IBA 01/2020 - 01/2018
3	AntigensIBA 10/2020 - 07/2014
2	Peptide Hydrolases (Proteases)FDA Link 10/2020 - 09/2003
2	MesothelinIBA 10/2020 - 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2024
1	InterferonsIBA 01/2022
1	LigandsIBA 01/2022
1	NucleotidesIBA 01/2022
1	1,2,3,4-tetrahydroisoquinolineIBA 11/2020
1	BenzodiazepinesIBA 11/2020
1	AntibodiesIBA 10/2020
1	DipeptidesIBA 10/2020
1	CarbamatesIBA 10/2020
1	Surface Antigens (Surface Antigen)IBA 10/2020
1	serum P-component (CIt)IBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	uncialamycinIBA 01/2019
1	GlypicansIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 07/2014
1	MDX-1203IBA 05/2013
1	Peptides (Polypeptides)IBA 09/2003
1	ProdrugsIBA 09/2003
1	N- (succinyl- beta- alanyl- L- leucyl- L- alanyl- L- leucyl)doxorubicinIBA 09/2003
1	Metalloproteases (Metalloproteinases)IBA 09/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	EnzymesIBA 09/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2003
1	Immunotherapy 02/2024
1	Drug Therapy (Chemotherapy) 01/2023